Osteopontin levels are elevated in patients with Asthma

Journal of International Medical Research

Volumn 39, Issue 4, 2011, Pages 1402-1407

  Zhao, J J ^a   Yang, L ^a   Zhao, F Q ^a   Shi, S M ^a   Tan, P ^a  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Asthma; Osteopontin; Th2 associated disease

Indexed keywords

OSTEOPONTIN;

ADULT; AGED; ARTICLE; ASTHMA; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PROTEIN BLOOD LEVEL;

EID: 80052240195     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900426     Document Type: Article

References (36)

1. Ashkar S, Weber GF, Panoutsakopoulou V, et al: Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000; 287: 860-864.
2. Rittling SR, Denhardt DT: Osteopontin function in pathology: lessons from osteopontin deficient mice. Exp Nephrol 1999; 7: 103-113.
3. O'Regan AW, Nau GJ, Chupp GL, et al: Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks. Immunol Today 2000; 21: 475-478.
4. Uede T, Katagiri Y, Iizuka J, et al: Osteopontin, a coordinator of host defense system: a cytokine or an extracellular adhesive protein? Microbiol Immunol 1997; 41: 641-648.
5. Denhardt DT, Noda M, O'Regan AW, et al: Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodelling, and cell survival. J Clin Invest 2001; 107: 1055-1061.
6. Xu G, Nie H, Li N, et al: Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin Invest 2005; 115: 1060-1067.
7. Comabella M, Pericot I, Goertsches R, et al: Plasma osteopontin levels in multiple sclerosis. J Neuroimmunol 2005; 158: 231-239.
8. O'Regan AW, Chupp GL, Lowry JA, et al: Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. J Immunol 1999; 162: 1024-1031.
9. Berman JS, Serlin D, Li X, et al: Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice. Am J Physiol Lung Cell Mol Physiol 2004; 286: L1311-L1318.
10. Möller GM, Overbeek SE, Van Helden-Meeuwsen CG, et al: Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients; down regulation by inhaled corticosteroids. Clin Exp Allergy 1996; 26: 517-524.
11. Broide DH: Immunologic and inflammatory mechanisms that drive asthma progression to remodelling. J Allergy Clin Immunol 2008; 121: 560-570.
12. Uchio E, Matsuura N, Kadonosono K, et al: Tear osteopontin levels in patients with allergic conjunctival diseases. Graefes Arch Clin Exp Ophthalmol 2002; 240: 924-928.
13. Xanthou G, Alissafi T, Semitekolou M, et al: Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med 2007; 13: 570-578.
14. Kohan M, Bader R, Puxeddu I, et al: Enhanced osteopontin expression in a murine model of allergen-induced airway remodelling. Clin Exp Allergy 2007; 37: 1444-1454.
15. Konno S, Golden DB, Schroeder J, et al: Increased expression of osteopontin is associated with long-term bee venom immunotherapy. J Allergy Clin Immunol 2005; 115: 1063-1067.
16. Simoes DC, Xanthou G, Petrochilou K, et al: Osteopontin deficiency protects against airway remodelling and hyper-responsiveness in chronic asthma. Am J Respir Crit Care Med 2009; 179: 894-902.
17. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987; 136: 225-244.
18. National Institutes of Health (NIH): Guidelines for the Diagnosis and Management of Asthma, NIH publication No. 97-4051. Washington, DC: NIH, 1997.
19. Weber GF, Zawaideh S, Hikita S, et al: Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. Leukoc Biol 2002; 72: 752-761.
20. Yamamoto N, Sakai F, Kon S, et al: Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J Clin Invest 2003; 112: 181-188.
21. Higuchi Y, Tamura Y, Uchida T, et al: The roles of soluble osteopontin using osteopontin-transgenic mice in vivo: proliferation of CD4+ T lymphocytes and the enhancement of cell-mediated immune responses. Pathobiology 2004; 71: 1-11.
22. Koh A, da Silva AP, Bansal AK, et al: Role of osteopontin in neutrophil function. Immunology 2007; 122: 466-475.
23. Ishii T, Ohshima S, Ishida T, et al: Osteopontin as a positive regulator in the osteoclastogenesis of arthritis. Biochem Biophys Res Commun 2004; 316: 809-815.
24. O'Regan AW, Hayden JM, Body S, et al: Abnormal pulmonary granuloma formation in osteopontin-deficient mice. Am J Respir Crit Care Med 2001; 164: 2243-2247.
25. Chabas D, Baranzini SE, Mitchell D, et al: The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001; 294: 1731-1735.
26. Koguchi Y, Kawakami K, Uezu K, et al: High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. Am J Respir Crit Care Med 2003; 167: 1355-1359.
27. Sato T, Nakai T, Tamura N, et al: Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Gut 2005; 54: 1254-1262.
28. Lu X, Zhang XH, Wang H, et al: Expression of osteopontin in chronic rhinosinusitis with and without nasal polyps. Allergy 2009; 64: 104-111.
29. Takahashi A, Kurokawa M, Konno S, et al: Osteopontin is involved in migration of eosinophils in asthma. Clin Exp Allergy 2009; 39: 1152-1159.
30. Mori R, Shaw TJ, Martin P: Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. J Exp Med 2008; 205: 43-51.
31. Nagasaka A, Matsue H, Matsushima H, et al: Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur J Immunol 2008; 38: 489-499.
32. Delimpoura V, Bakakos P, Tseliou E, et al: Increased levels of osteopontin in sputum supernatant in severe refractory asthma. Thorax 2010; 65: 782-786.
33. Blom T, Franzén A, Heinegård D, et al: Comment on "The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease". Science 2003; 299: 1845.
34. Abel B, Freigang S, Bachmann MF, et al: Osteopontin is not required for the development of Th1 responses and viral immunity. J Immunol 2005; 175: 6006-6013.
35. Crawford HC, Matrisian LM, Liaw L: Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo. Cancer Res 1998; 58: 5206-5215.
36. Sodek J, Chen J, Nagata T, et al: Regulation of osteopontin expression in osteoblasts. Ann N Y Acad Sci 1995; 760: 223-241.